TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
The review article provides with recent data on the crucial cardiology problems — duration of double antiplatelet therapy (DAPT) in patients with different types of ischemic heart disease. The analysis is provided of actual clinical guidelines on this issue, the results of recent clinical trials are...
Main Authors: | O. L. Barbarash, V. V. Kashtalap |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2016-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/520 |
Similar Items
-
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials
by: Jorge Sanz-Sánchez, et al.
Published: (2021-08-01) -
MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01) -
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
by: Masashi Kubota, et al.
Published: (2024-03-01) -
Percutaneous native kidney biopsy in patients receiving antiplatelet agents- is it necessary to stop them routinely?
by: S Nayak-Rao
Published: (2015-01-01) -
Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
by: Georges Jourdi, et al.
Published: (2021-12-01)